IFF Pharma Solutions showcased breakthrough research at AAPS 2024 PharmSci 360 in Salt Lake City, Utah, from October 20-23. The presentations highlighted the critical role of excipients in drug formulation and unveiled key advancements in the field.
The research focused on several areas, including nitrosamine risk mitigation, controlled-release performance, and extrusion spheronization processibility. Additionally, IFF Pharma Solutions presented findings on pellet quality, softgel stability, and the formulation of various pharmaceutical products.
These advancements demonstrate IFF's commitment to scientific discovery and its ability to provide innovative solutions for complex drug delivery challenges. Such research efforts are crucial for maintaining a competitive edge and supporting customer needs in the pharmaceutical industry.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.